Authors/Disclosures
|
|
No disclosure on file |
|
Paul Smith
|
No disclosure on file |
|
|
No disclosure on file |
|
David J. Libon, PhD
(Rowan Univerity)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Luisa Rojas, MD
(Dent Neurologic Institute)
|
No disclosure on file |
|
Anahita F. Deboo, MD
(Temple University School of Medicine - Neurology)
|
Dr. Deboo has nothing to disclose. |
|
Terry D. Heiman-Patterson, MD
(Temple University Lewis Katz School of Medicine)
|
Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation. |